financetom
Business
financetom
/
Business
/
LQR House Acquires Stake in DRNK Beverage for $4.8 Million
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
LQR House Acquires Stake in DRNK Beverage for $4.8 Million
Jun 10, 2024 7:33 AM

10:27 AM EDT, 06/10/2024 (MT Newswires) -- LQR House ( LQR ) said Monday it has acquired 1.92 million shares of DRNK Beverage for a total of $4.8 million.

The shares, which represent a roughly 8.6% stake in DRNK, were bought at $2.50 per share, LQR said.

Through this investment, the company said it will be able to enter the non-alcoholic and ready-to-drink beverage markets.

Shares of LQR added 2.1% in recent trading on Monday.

Price: 1.02, Change: +0.02, Percent Change: +2.10

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Generation Mining Secures Additional Permit Approvals for Marathon Copper-Palladium Project in Ontario
Generation Mining Secures Additional Permit Approvals for Marathon Copper-Palladium Project in Ontario
Mar 3, 2025
08:51 AM EST, 03/03/2025 (MT Newswires) -- Generation Mining ( GENMF ) said Monday that it received two additional permits for the Marathon copper-palladium project in Ontario. The company secured a permit to take water from the Ministry of the Environment, Conservation and Parks (MECP). This is one of the four approvals for the Lakes and Rivers Improvement Act permit,...
Protagonist, Takeda Say Phase 3 Study of Rusfertide Meets Endpoints in Polycythemia Vera
Protagonist, Takeda Say Phase 3 Study of Rusfertide Meets Endpoints in Polycythemia Vera
Mar 3, 2025
09:00 AM EST, 03/03/2025 (MT Newswires) -- Protagonist Therapeutics ( PTGX ) and Takeda (TAK) said Monday that a phase 3 study of investigational drug rusfertide as a potential add-on to standard of care treatment for polycythemia vera, a form of blood cancer, met the primary and key secondary endpoints. The companies said Protagonist will earn a milestone payment of...
Walker & Dunlop Plans $400 Million Senior Notes Offering
Walker & Dunlop Plans $400 Million Senior Notes Offering
Mar 3, 2025
09:01 AM EST, 03/03/2025 (MT Newswires) -- Walker & Dunlop ( WD ) said Monday it intends to offer $400 million in senior unsecured notes due 2033 through a private placement. In conjunction with the notes offering, the company said it plans to amend and restate its senior secured term loan agreement, reducing the outstanding loans to $450 million, extending...
Valley National Bancorp Names Travis Lan Finance Chief
Valley National Bancorp Names Travis Lan Finance Chief
Mar 3, 2025
09:01 AM EST, 03/03/2025 (MT Newswires) -- Valley National Bancorp ( VLY ) said Monday it has named Travis Lan as chief financial officer, a position he has held on an interim basis. The company also appointed Gino Martocci as president of Commercial Banking. He succeeds Joe Chillura, who is leaving the company effective June 30. Martocci previously served as...
Copyright 2023-2026 - www.financetom.com All Rights Reserved